Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 1.00 |
| ▸ | SLC2A1 | P11166 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 1.00 |
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | EPAS1 | Q99814 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | STAT6 | P42226 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | RBBP9 | O75884 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Emetine SCHEMBL14135123 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL29392786 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL14261157 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL29390500 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL13226748 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL14269958 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL24499457 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL14029342 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL13912579 | 1.00 | HIF1A (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 | |
| Emetine SCHEMBL2382448 | 0.99 | MEN1 (1.00) | HIF1AMEN1KMT2ASMN1; SMN2SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 23021 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137650-A1 | MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs) | 11949098 CANADA INC (CA) | 2026-05-21 | — | — | US | claimed |
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| WO-2026087695-A1 | TREATMENT FOR METABOLIC DISORDER | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| EP-4709383-A1 | INVERSE AGONISTS OF RAR RELATED ORPHAN RECEPTORS (RORS) | 11949098 Canada Inc. (CA) | 2026-03-18 | — | — | EP | claimed |
| US-12577324-B2 | Antibodies having specificity to HER4 and uses thereof | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2026-03-17 | — | — | US | claimed |
| EP-4704811-A1 | MODIFIED LIPOSOME FOR DRUG DELIVERY, USE OF LIPOSOME FOR DRUG DELIVERY, ESPECIALLY WITH ANTI-CANCER ACTIVITY, AND WAYS TO LOAD LIPOSOME WITH DRUGS, ESPECIALLY WITH ANTI-CANCER ACTIVITY | BS Biotechna Spolka Akcyjna (PL) | 2026-03-11 | — | — | EP | claimed |
| EP-4704812-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING EMETINE AND MITOXANTRONE FOR THE PREVENTION OR TREATMENT OF MAMMARY GLAND CANCER AND A LIPOSOME CONTAINING THIS COMPOSITION | BS Biotechna Spolka Akcyjna (PL) | 2026-03-11 | — | — | EP | claimed |
| US-12550885-B2 | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells | UNIVERSITY OF CINCINNATI (US) | 2026-02-17 | — | — | US | claimed |
| US-20250381202-A1 | PRODRUG KIT FOR MULTI-PRONGED CHEMOTHERAPY | ZOUNEK ALEX (DE) | 2025-12-18 | — | — | US | claimed |
| EP-4658278-A1 | SELECTIVE FIASMA TREATMENT | Valo Health, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| EP-0037175-B1 | PHARMACEUTICAL COMPOSITIONS | EFAMOL LIMITED (GB) | 1988-02-10 | — | — | EP | claimed |
| EP-0239102-A2 | Process for the formation of human-human hybridoma | Tsuji, Kimiyoshi (JP) | 1987-09-30 | — | — | EP | claimed |
| US-4675295-A | Process for producing subculturable lymphokine-producing human T cell hybridomas | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-06-23 | — | — | US | claimed |
| EP-0174810-A2 | Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein DNA | HSC Research Development Corporation (CA) | 1986-03-19 | — | — | EP | claimed |
| US-4529583-A | Composition and method of immobilizing emetics and method of treating human beings with emetics | CLEAR LAKE DEVELOPMENT GROUP (US) | 1985-07-16 | — | — | US | claimed |
| US-4459278-A | Composition and method of immobilizing emetics and method of treating human beings with emetics | CLEAR LAKE DEVELOPMENT GROUP (US) | 1984-07-10 | — | — | US | claimed |
| EP-0035856-B1 | PHARMACEUTICAL AND DIETARY COMPOSITIONS | EFAMOL LIMITED (GB) | 1984-07-04 | — | — | EP | claimed |
| EP-0037175-A1 | Pharmaceutical compositions | EFAMOL LIMITED (GB) | 1981-10-07 | — | — | EP | claimed |
| EP-0035856-A2 | Pharmaceutical and dietary compositions | EFAMOL LIMITED (GB) | 1981-09-16 | — | — | EP | claimed |
| US-4175119-A | Composition and method to prevent accidental and intentional overdosage with psychoactive drugs | PORTER GARRY L | 1979-11-20 | — | — | US | claimed |